NEULAND LABORATORIES
Back to All Ratios
|
NEULAND LABORATORIES Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 17.61 | 19.25 | 13.73 | 6.71 | 8.61 |
What is the latest Profit After Tax (PAT) Margin ratio of NEULAND LABORATORIES ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 17.61 |
| Mar2024 | 19.25 |
| Mar2023 | 13.73 |
| Mar2022 | 6.71 |
| Mar2021 | 8.61 |
How is Profit After Tax (PAT) Margin of NEULAND LABORATORIES Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 17.61 | -8.52 | |
| Mar2024 | 19.25 | 40.20 | |
| Mar2023 | 13.73 | 104.62 | |
| Mar2022 | 6.71 | -22.07 | |
| Mar2021 | 8.61 | - | |
Other Financial Ratios of NEULAND LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,203.1 Cr | 0.7% | 12.5% | 57.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.7% |
12.5% |
57.1% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses